Atossa Therapeutics Inc (ATOS)
1.30
0.00 (0.00%)
USD |
NASDAQ |
May 31, 16:00
1.305
0.00 (0.00%)
After-Hours: 20:00
Atossa Therapeutics Cash from Investing (Quarterly): -0.006M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -0.006M |
December 31, 2023 | 0.00 |
September 30, 2023 | -0.001M |
June 30, 2023 | -0.013M |
March 31, 2023 | 0.00 |
December 31, 2022 | -2.008M |
September 30, 2022 | -2.706M |
June 30, 2022 | 0.00 |
March 31, 2022 | -0.013M |
December 31, 2021 | 0.00 |
September 30, 2021 | -0.009M |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | -0.0028M |
June 30, 2020 | -0.0066M |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | -0.0076M |
March 31, 2019 | 0.00 |
December 31, 2018 | -0.0565M |
September 30, 2018 | -0.003M |
June 30, 2018 | -0.0004M |
March 31, 2018 | -0.0511M |
Date | Value |
---|---|
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | -0.0042M |
September 30, 2016 | -0.0001M |
June 30, 2016 | 0.0001M |
March 31, 2016 | -0.005M |
December 31, 2015 | -0.1777M |
September 30, 2015 | -0.0291M |
June 30, 2015 | -0.0156M |
March 31, 2015 | -0.066M |
December 31, 2014 | -0.0557M |
September 30, 2014 | -0.0964M |
June 30, 2014 | -0.0881M |
March 31, 2014 | -0.103M |
December 31, 2013 | -0.0891M |
September 30, 2013 | -0.3108M |
June 30, 2013 | -0.0814M |
March 31, 2013 | -0.0085M |
December 31, 2012 | -0.1346M |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | -0.0517M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-2.706M
Minimum
Sep 2022
--
Maximum
Sep 2019
-0.2386M
Average
-0.0005M
Median
Cash from Investing (Quarterly) Benchmarks
AngioDynamics Inc | 29.40M |
Achieve Life Sciences Inc | -- |
Biolase Inc | 0.197M |
Outset Medical Inc | -59.03M |
Perspective Therapeutics Inc | -47.30M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -4.698M |
Cash from Financing (Quarterly) | 0.204M |
Free Cash Flow | -18.64M |
Free Cash Flow Per Share (Quarterly) | -0.0375 |
Free Cash Flow Yield | -11.40% |